← FDA Drug Approvals (Drugs@FDA)
ROMVIMZA
NDA · New Drug Application · Sponsor: DECIPHERA PHARMS · Approved 2025-02-14
Drug application
- FDA Application #
NDA219304- Application type
- New Drug Application
- Brand name
- ROMVIMZA
- Generic name
- VIMSELTINIB
- Active ingredients
- VIMSELTINIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- DECIPHERA PHARMS
- Manufacturer
- Deciphera Pharmaceuticals, LLC
- First approval
- 2025-02-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown